Position paper on screening for breast cancer by the European Society of Breast Imaging (EUSOBI) and 30 national breast radiology bodies from Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Israel, Lithuania, Moldova, The Netherlands, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerland and Turkey
Francesco Sardanelli
(1)
,
Hildegunn Aase
(2)
,
Marina Álvarez
(3)
,
Edward Azavedo
(4)
,
Henk Baarslag
(5)
,
Corinne Balleyguier
(6)
,
Pascal Baltzer
(7)
,
Vanesa Beslagic
(8)
,
Ulrich Bick
(9)
,
Dragana Bogdanovic-Stojanovic
(10)
,
Ruta Briediene
(11)
,
Boris Brkljacic
(12)
,
Julia Camps Herrero
(13)
,
Catherine Colin
(14)
,
Eleanor Cornford
(15)
,
Jan Danes
(16)
,
Gérard de Geer
(17)
,
Gul Esen
(18)
,
Andrew Evans
(19)
,
Michael Fuchsjaeger
(20)
,
Fiona Gilbert
(21)
,
Oswald Graf
,
Gormlaith Hargaden
(22)
,
Thomas Helbich
(7)
,
Sylvia Heywang-Köbrunner
,
Valentin Ivanov
(23)
,
Ásbjörn Jónsson
(24)
,
Christiane Kuhl
(25)
,
Eugenia Lisencu
(26)
,
Elzbieta Luczynska
(27)
,
Ritse Mann
(28)
,
José Marques
(29)
,
Laura Martincich
,
Margarete Mortier
(30)
,
Markus Müller-Schimpfle
,
Katalin Ormandi
,
Pietro Panizza
,
Federica Pediconi
,
Ruud Pijnappel
,
Katja Pinker
,
Tarja Rissanen
,
Natalia Rotaru
,
Gianni Saguatti
,
Tamar Sella
,
Jana Slobodníková
,
Maret Talk
,
Patrice Taourel
(31)
,
Rubina Trimboli
,
Ilse Vejborg
,
Athina Vourtsis
,
Gabor Forrai
1
UNIMI -
Università degli Studi di Milano = University of Milan
2 Haukeland University Hospital
3 Hospital Reina Sofia, Cordoba
4 Karolinska University Hospital [Stockholm]
5 Meander Medical Center
6 Département d'imagerie médicale [Gustave Roussy]
7 Medizinische Universität Wien = Medical University of Vienna
8 Clinical Center University of Sarajevo
9 Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
10 Institutski put 4
11 Vilnius University [Vilnius]
12 University Hospital Centre Zagreb and University of Zagreb School of Medicine
13 Hospital de la Ribera
14 CHLS - Centre Hospitalier Lyon Sud [CHU - HCL]
15 NUH - Nottingham University Hospitals NHS Trust
16 IUUK - Computer Science Institute of Charles University [Prague]
17 ImageRive
18 Acibadem University
19 Ninewells Hospital and Medical School [Dundee]
20 Medical University Graz
21 CAM - University of Cambridge [UK]
22 The Mater Hospital - Mater Misericordiae University Hospital
23 Tokuda Hospital Sofia
24 Value Chain, Processing and Aquaculture
25 Landspitalinn University Hospital, Reykjavik
26 Department of Medicine III, University hospital (UKA), University of Aachen (RWTH)
27 The Oncology Institute 'Prof. Dr. Ion Chiricuta'
28 Radboud University Medical Center [Nijmegen]
29 UC - University of Coimbra [Portugal]
30 Ghent University Hospital
31 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
2 Haukeland University Hospital
3 Hospital Reina Sofia, Cordoba
4 Karolinska University Hospital [Stockholm]
5 Meander Medical Center
6 Département d'imagerie médicale [Gustave Roussy]
7 Medizinische Universität Wien = Medical University of Vienna
8 Clinical Center University of Sarajevo
9 Charité - UniversitätsMedizin = Charité - University Hospital [Berlin]
10 Institutski put 4
11 Vilnius University [Vilnius]
12 University Hospital Centre Zagreb and University of Zagreb School of Medicine
13 Hospital de la Ribera
14 CHLS - Centre Hospitalier Lyon Sud [CHU - HCL]
15 NUH - Nottingham University Hospitals NHS Trust
16 IUUK - Computer Science Institute of Charles University [Prague]
17 ImageRive
18 Acibadem University
19 Ninewells Hospital and Medical School [Dundee]
20 Medical University Graz
21 CAM - University of Cambridge [UK]
22 The Mater Hospital - Mater Misericordiae University Hospital
23 Tokuda Hospital Sofia
24 Value Chain, Processing and Aquaculture
25 Landspitalinn University Hospital, Reykjavik
26 Department of Medicine III, University hospital (UKA), University of Aachen (RWTH)
27 The Oncology Institute 'Prof. Dr. Ion Chiricuta'
28 Radboud University Medical Center [Nijmegen]
29 UC - University of Coimbra [Portugal]
30 Ghent University Hospital
31 CHRU Montpellier - Centre Hospitalier Régional Universitaire [Montpellier]
Francesco Sardanelli
- Fonction : Auteur
- PersonId : 893261
Corinne Balleyguier
- Fonction : Auteur
- PersonId : 1241668
- ORCID : 0000-0002-0018-8731
- IdRef : 074537695
Oswald Graf
- Fonction : Auteur
Sylvia Heywang-Köbrunner
- Fonction : Auteur
Laura Martincich
- Fonction : Auteur
Markus Müller-Schimpfle
- Fonction : Auteur
Katalin Ormandi
- Fonction : Auteur
Pietro Panizza
- Fonction : Auteur
Federica Pediconi
- Fonction : Auteur
Ruud Pijnappel
- Fonction : Auteur
Katja Pinker
- Fonction : Auteur
Tarja Rissanen
- Fonction : Auteur
Natalia Rotaru
- Fonction : Auteur
Gianni Saguatti
- Fonction : Auteur
Tamar Sella
- Fonction : Auteur
Jana Slobodníková
- Fonction : Auteur
Maret Talk
- Fonction : Auteur
Patrice Taourel
- Fonction : Auteur
- PersonId : 790999
- IdHAL : patrice-taourel
- ORCID : 0000-0001-6465-1919
- IdRef : 055746527
Rubina Trimboli
- Fonction : Auteur
Ilse Vejborg
- Fonction : Auteur
Athina Vourtsis
- Fonction : Auteur
Gabor Forrai
- Fonction : Auteur
Résumé
EUSOBI and 30 national breast radiology bodies support mammography for population-based screening, demonstrated to reduce breast cancer (BC) mortality and treatment impact. According to the International Agency for Research on Cancer, the reduction in mortality is 40 % for women aged 50-69 years taking up the invitation while the probability of false-positive needle biopsy is <1 % per round and overdiagnosis is only 1-10 % for a 20-year screening. Mortality reduction was also observed for the age groups 40-49 years and 70-74 years, although with "limited evidence". Thus, we firstly recommend biennial screening mammography for average-risk women aged 50-69 years; extension up to 73 or 75 years, biennially, is a second priority, from 40-45 to 49 years, annually, a third priority. Screening with thermography or other optical tools as alternatives to mammography is discouraged. Preference should be given to population screening programmes on a territorial basis, with double reading. Adoption of digital mammography (not film-screen or phosphor-plate computer radiography) is a priority, which also improves sensitivity in dense breasts. Radiologists qualified as screening readers should be involved in programmes. Digital breast tomosynthesis is also set to become "routine mammography" in the screening setting in the next future. Dedicated pathways for high-risk women offering breast MRI according to national or international guidelines and recommendations are encouraged.